Drug Shipments Into U.S. Could Depend On Facility Inspection; FDA Mulls Import Alerts

Foreign drug manufacturers may face refusal of their products at the U.S. border if they do not submit to an FDA inspection, another part of the agency’s growing effort to increase oversight of the global marketplace.